Company / Book Value per Share
ROCKET PHARMACEUTICALS, INC. Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$4.352
FY2025
5-year range
$4.352 / $7.806
FY2021-FY2025
Trend
-20.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has declined for 3 consecutive years, from $7.806 in FY2022 to $4.352 in FY2025.
Based on SEC 10-K filings.
$4.352 in FY2025 with a 5-year CAGR of +4.2%.
Declined from $5.747 to $4.352 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -17.7%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- ROCKET PHARMACEUTICALS, INC.'s book value per share has declined for 3 consecutive years.
- 5-year CAGR of +4.2%, indicating consistent growth.
- In FY2025, book value per share decreased 20.2% year-over-year.
- Peak book value per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.68 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.352 | -20.2% |
| FY2024 | $5.456 | -5.1% |
| FY2023 | $5.747 | -26.4% |
| FY2022 | $7.806 | +54.9% |
| FY2021 | $5.038 | +42.2% |
| FY2020 | $3.543 | +930.6% |
| FY2019 | $0.344 | -84.9% |
| FY2018 | $2.284 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026